ArticleFrontiers in cardiovascular medicine2026
SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) presents with a wide spectrum of clinical manifestations. While primarily affecting the respiratory system, neurological involvement and thromboembolic complications have also been documented. This report describes a rare case of a 25-year-old male who developed acute longitudinally extensive transverse myelitis (LETM) complicated by pulmonary embolism (PE) and deep vein thrombosis (DVT) of the lower extremities following SARS-CoV-2 infection. The patient presented with acute chest tightness and pain, followed by high fever, which rapidly progressed to quadriplegia and sensory deficits. Magnetic resonance imaging (MRI) revealed abnormal signal intensity in the spinal cord from the C4 to T1 levels. Computed tomography pulmonary angiography (CTPA) confirmed PE, and laboratory tests were positive for SARS-CoV-2 nucleic acid. Although aquaporin-4 (AQP4), myelin oligodendrocyte glycoprotein (MOG), and glial fibrillary acidic protein (GFAP) antibodies were negative, cerebrospinal fluid analysis indicated inflammatory changes. Partial clinical improvement was achieved following treatment with high-dose corticosteroid pulse therapy, anticoagulation, and antiviral agents. This case highlights the potential of COVID-19 to simultaneously trigger neurological and vascular complications, underscoring the complexity of multi-system involvement by the virus. The underlying pathophysiological mechanisms involving potential "virus-immune-thrombosis" interactions are discussed in depth, providing important insights for clinicians to recognize and manage such complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.